Retatrutide : GI adverse events dose-dependent
Thus, the group size was chosen based on practical considerations and previous studies in our laboratory with RYGB patients [16,17,18]
Your healthcare team can develop a personalised management plan that balances maternal metabolic health with infant safety throughout the lactation period and beyond
Before any dose change: discuss your symptoms, hydration, food intake, bowel habits, treatment response and other medications with your prescribing healthcare provider
It's a potentially important finding, as previous studies have suggested that rapid weight loss with GLP-1 drugs like semaglutide can be accompanied by muscle loss of 20% to 40%, which has prompted the development of treatments to offset those declines and improve body composition
GI Tolerability Differences Some patients experience persistent nausea on semaglutide but find tirzepatide easier to tolerate at equivalent dose stages, or vice versa